These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16831899)

  • 1. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.
    Lenac T; Budt M; Arapovic J; Hasan M; Zimmermann A; Simic H; Krmpotic A; Messerle M; Ruzsics Z; Koszinowski UH; Hengel H; Jonjic S
    J Exp Med; 2006 Aug; 203(8):1843-50. PubMed ID: 16831899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promiscuity of MCMV immunoevasin of NKG2D: m138/fcr-1 down-modulates RAE-1epsilon in addition to MULT-1 and H60.
    Arapović J; Lenac Rovis T; Reddy AB; Krmpotić A; Jonjić S
    Mol Immunol; 2009 Nov; 47(1):114-22. PubMed ID: 19297023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions.
    Lodoen MB; Abenes G; Umamoto S; Houchins JP; Liu F; Lanier LL
    J Exp Med; 2004 Oct; 200(8):1075-81. PubMed ID: 15477345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein.
    Hasan M; Krmpotic A; Ruzsics Z; Bubic I; Lenac T; Halenius A; Loewendorf A; Messerle M; Hengel H; Jonjic S; Koszinowski UH
    J Virol; 2005 Mar; 79(5):2920-30. PubMed ID: 15709011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145.
    Krmpotic A; Hasan M; Loewendorf A; Saulig T; Halenius A; Lenac T; Polic B; Bubic I; Kriegeskorte A; Pernjak-Pugel E; Messerle M; Hengel H; Busch DH; Koszinowski UH; Jonjic S
    J Exp Med; 2005 Jan; 201(2):211-20. PubMed ID: 15642742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.
    Dunn C; Chalupny NJ; Sutherland CL; Dosch S; Sivakumar PV; Johnson DC; Cosman D
    J Exp Med; 2003 Jun; 197(11):1427-39. PubMed ID: 12782710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-dependent down-regulation of the NKG2D ligand H60 on tumors.
    Bui JD; Carayannopoulos LN; Lanier LL; Yokoyama WM; Schreiber RD
    J Immunol; 2006 Jan; 176(2):905-13. PubMed ID: 16393975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60.
    O'Callaghan CA; Cerwenka A; Willcox BE; Lanier LL; Bjorkman PJ
    Immunity; 2001 Aug; 15(2):201-11. PubMed ID: 11520456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
    Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C
    J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D.
    Takada A; Yoshida S; Kajikawa M; Miyatake Y; Tomaru U; Sakai M; Chiba H; Maenaka K; Kohda D; Fugo K; Kasahara M
    J Immunol; 2008 Feb; 180(3):1678-85. PubMed ID: 18209064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines.
    Hiršl L; Brizić I; Jenuš T; Juranić Lisnić V; Reichel JJ; Jurković S; Krmpotić A; Jonjić S
    Front Immunol; 2018; 9():991. PubMed ID: 29867968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
    Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
    Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions.
    Sutherland CL; Chalupny NJ; Cosman D
    Immunol Rev; 2001 Jun; 181():185-92. PubMed ID: 11513139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
    Song H; Kim J; Cosman D; Choi I
    Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.
    Cosman D; Müllberg J; Sutherland CL; Chin W; Armitage R; Fanslow W; Kubin M; Chalupny NJ
    Immunity; 2001 Feb; 14(2):123-33. PubMed ID: 11239445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40.
    Pinto AK; Jamieson AM; Raulet DH; Hill AB
    J Virol; 2007 Nov; 81(22):12564-71. PubMed ID: 17855532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKG2D-independent suppression of T cell proliferation by H60 and MICA.
    Kriegeskorte AK; Gebhardt FE; Porcellini S; Schiemann M; Stemberger C; Franz TJ; Huster KM; Carayannopoulos LN; Yokoyama WM; Colonna M; Siccardi AG; Bauer S; Busch DH
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11805-10. PubMed ID: 16091471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.
    Lodoen M; Ogasawara K; Hamerman JA; Arase H; Houchins JP; Mocarski ES; Lanier LL
    J Exp Med; 2003 May; 197(10):1245-53. PubMed ID: 12756263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
    Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D.
    Bacon L; Eagle RA; Meyer M; Easom N; Young NT; Trowsdale J
    J Immunol; 2004 Jul; 173(2):1078-84. PubMed ID: 15240696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.